11th International Conference on Alzheimer's Drug Discovery

September 27-28, 2010  Jersey City, NJ (across from NYC on the Hudson)

HOME   |   PROGRAM   |   SPEAKERS   |   SCHOLARSHIPS   |   REGISTRATION   |   ACCOMMODATIONS   |   SPONSORSHIP   |   SUPPORTERS   |   CONTACT

The 11th International Conference on Alzheimer's Disease Drug Discovery was presented by the Alzheimer's Drug Discovery Foundation (ADDF), the only public charity solely dedicated to rapidly accelerating the discovery and development of drugs to prevent, treat and cure Alzheimer's disease and cognitive aging.  This conference brought together academic and industry scientists to accelerate the development of innovative treatments for Alzheimer’s disease and related dementias.  Speakers presented their current research, provided updates and stimulated discussion among attendees.

READ CONFERENCE REPORT:

A diverse portfolio of novel drug discovery efforts for Alzheimer's disease: Meeting report from the 11th International Conference on Alzheimer's Drug Discovery, 27-28 September 2010, Jersey City, NJ, USA

Linda H Lee, Diana W Shineman, Howard M Fillit Alzheimer's Research & Therapy 2010, 2:33 (15 December 2010)

CONFERENCE OBJECTIVES   TARGET AUDIENCE   2010 SCHOLARSHIPS   EXHIBIT/SPONSORSHIP   PAST PROGRAMS

The objectives of the conference are:

 

Highlight scientific progress on drug discovery programs aimed at treating Alzheimer’s disease and related dementias.

 

Increase networking opportunities for scientists to share information and resources.

 

Foster interdisciplinary and public-private partnerships and alliances.

 

The 2009 edition of this conference attracted attendees from around the globe.  Attendees included:

 

Academic and industry scientists engaged in drug discovery research for neurodegenerative diseases or CNS

Business development and licensing professionals

Alliance management professionals

Venture capitalists and other investors.

 

The Alzheimer’s Drug Discovery Foundation invites applications for the 2010 ADDF Young Investigator Scholarships. 

 

Click here to review the list of winners.

 

 

The 11th International Conference on Alzheimer’s Disease Drug Discovery offers a great opportunity to expand your company's visibility among the registrants by becoming a conference sponsor and/or exhibitor.  

Review the ample options and contact us today!

 

 

2009 PROGRAM

 

2008 PROGRAM

 

Click here to read the 2009 conference summary authored by Dr. Diana Shineman, ADDF's Director of Scientific Affairs. 

 

Review also ADDF's "sister" conference on neurodegenerative diseases.

 

All links in this column will open new windows.

 

TOP